Hexarelin
$43.99 – $62.99Price range: $43.99 through $62.99
One of the most potent synthetic GH secretagogues, stimulating powerful GH release along with cardioprotective effects.
Molecular & analytical data
Verified chemistry and third-party reference identifiers for this compound.

Reconstitution calculator
Concentration, volume per draw, and the graduation it measures to. Open the full bench calculator with this vial loaded →
—
A U-100 insulin syringe reads 100 units per 1 mL. Figures describe the contents of a vial for laboratory handling reference only and are not dosing guidance.
Quality & verification
Every batch is characterised before release and ships with documentation.
Storage & handling
Keep the peptide stable from delivery through reconstitution.
Lyophilized at -20°C. Reconstituted at 2-8°C.
Hexarelin (also known as Examorelin) is one of the strongest synthetic growth hormone releasing peptides available. It produces more robust GH pulses than GHRP-2 or GHRP-6 but also has more pronounced side effects including significant cortisol and prolactin elevation. Uniquely, Hexarelin has demonstrated cardioprotective properties independent of GH release, through direct action on cardiac tissue. However, it is subject to desensitization with prolonged use, making cycling necessary.
Certificates of Analysis
Every batch of this peptide is tested before release. Find the batch number printed on your vial and verify or download its certificate.
| Batch # | Issued | Purity | Certificate |
|---|---|---|---|
| NHV26-J2347 COA-8SF9-TG4Q-Y | 04 Aug 2026 | 99.07 % HPLC | Verify at IRZC ↗ |
“Verify at IRZC” opens the laboratory’s own record for that certificate, on their site. Looking for an older batch we haven’t published? Email [email protected] with the batch number from your vial — we keep all certificates for 7 years.
The information below summarises published preclinical and clinical research for scientific reference. NHOV products are sold strictly for laboratory research use only. Nothing here is medical advice, a recommendation, or an instruction for use in humans or animals.
Mechanism of action
Potent ghrelin receptor agonist, strongest GH pulse of GHRPs, cardioprotective effects via CD36 receptor, increases cortisol and prolactin, subject to tachyphylaxis with chronic use.
Primary uses / indications
Maximum GH stimulation research, cardioprotection studies, muscle growth, body composition
Typical dosage (reported)
100-200 mcg per injection, 2-3 times daily. Cycle to prevent desensitization.
Cycle duration (reported)
4-8 weeks maximum due to desensitization; requires cycling
Administration route
Subcutaneous injection, Intravenous (research)
Side effects (reported)
Significant cortisol and prolactin elevation, intense hunger, water retention, desensitization with prolonged use, injection site reactions.
Contraindications
Active cancer, pituitary disorders, hyperprolactinemia, cardiac conditions, pregnancy/breastfeeding
Drug interactions
Synergistic with GHRH analogs. Subject to desensitization — cycling required.
Identity
| Full name / brand names | Hexarelin (Examorelin) |
|---|---|
| Category | Growth Hormone Secretagogues |
| Subcategory | Ghrelin Receptor Agonist (GHS) |
| Origin / source | Synthetic hexapeptide |
| Year discovered | 1990s |
Chemistry
| Amino acid sequence | His-D-2MeTrp-Ala-Trp-D-Phe-Lys-NH2 |
|---|---|
| Molecular formula | C47H58N12O6 |
| Molecular weight | 887.04 g/mol |
| CAS number | 140703-51-1 |
| PubChem CID | CID 6918297 ↗ |
| Purity standard | ≥98% |
Pharmacokinetics
| Half-life | ~70 minutes |
|---|---|
| Bioavailability | Subcutaneous: ~77%; Intranasal: ~4.8%; Oral: ~0.3% (biological bioavailability, Ghigo et al. 1994) |
Regulatory & research status
| FDA status | Not FDA-approved. Research chemical only. |
|---|---|
| Prescription required | Research use only |
| Research status | Clinical studies for GH deficiency and cardioprotection; not approved |
| Clinical trials | Phase II trials (GH deficiency, cardiac function) |
References
Ghigo E, Arvat E, Gianotti L, Imbimbo BP, Lenaerts V, Deghenghi R, Camanni F, "Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man", Journal of Clinical Endocrinology & Metabolism, 1994;78(3):693-698, DOI: 10.1210/jcem.78.3.8126144; Arvat E et al., "Effects of short-term continuous infusion of human GHRH and hexarelin on GH release", Journal of Endocrinological Investigation, 1994
Frequently asked questions
What is Hexarelin?
How does Hexarelin work?
What Hexarelin dosage is used in research?
What is the half-life of Hexarelin?
How should Hexarelin be stored and reconstituted?
What purity is NHOV's Hexarelin?
Is Hexarelin approved for human use?
Related products
CJC-1295
Synthetic long-acting GHRH analog studied for pituitary GH-release research.
$39.99 – $64.99Price range: $39.99 through $64.99Ipamorelin
Selective GHS-R1a agonist noted for minimal cortisol and prolactin activity.
$36.99 – $54.99Price range: $36.99 through $54.99
Pre-order 
MK-677
Orally active non-peptide ghrelin receptor agonist studied for GH-axis research.
$74.99 – $129.99Price range: $74.99 through $129.99Sermorelin
Truncated 29-amino-acid GHRH analog studied for pituitary GH-release research.
$42.99 – $63.99Price range: $42.99 through $63.99CJC-1295 with DAC
GHRH analog with a Drug Affinity Complex that binds albumin for a 6-8 day half-life.
$41.99 – $66.99Price range: $41.99 through $66.99Tesamorelin
44-amino-acid GHRH analog investigated in visceral adipose tissue research.
$41.99 – $66.99Price range: $41.99 through $66.99GHRP-2
Potent hexapeptide ghrelin receptor agonist; mild cortisol and prolactin activity.
$24.99 – $32.99Price range: $24.99 through $32.99GHRP-6
First-generation hexapeptide GHS; marked ghrelin mimicry and appetite signaling.
$21.99 – $37.99Price range: $21.99 through $37.99











Reviews
Clear filtersThere are no reviews yet.